Cell and gene therapies to date have demonstrated promising potential against certain cancers and hereditary diseases, and are poised to lead the healthcare shift into precision medicine over the next decade.

Join us at BIO Asia–Taiwan 2021 to understand current developments, the growing cell and gene therapy ecosystem, regulatory conditions, and how to set up clinical trials for cell and gene therapies in Asia. Another segment to watch is biodesign for medical devices, where collaborations with international medical device partners—such as the Stanford Biodesign program—are changing the landscape of medical device innovation in Asia.

Register now to gain in-depth insight in these two cutting-edge fields at BIO Asia–Taiwan 2021!

Hear from Experts

Session 11 –  Advances in Cell & Gene Therapies

Distinguished Speakers

Hear from Experts

Session 13 – Asian Biodesign- Accelerating to Meet the Medical Needs

Distinguished Speakers

Who should attend?

• Leaders and professionals in the novel therapies and biodesign ecosystem
• Providers of novel therapies and biodesign solutions and services
• Policymakers, researchers, and educators in the fields of novel therapies and biodesign 

Thanks to Our Partners and Sponsors